Disclosures for "Atrial Fibrillation and Stroke: Predictors of Anticoagulation Therapy Modification")
-
Mrs. Carvalho de Oliveira has nothing to disclose.
-
Mr. Webb has nothing to disclose.
-
Dr. Ponciano has nothing to disclose.
-
Prof. Farias Da Guarda has nothing to disclose.
-
Ms. Yilmaz has nothing to disclose.
-
An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (Education) with Biogen.
-
Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
-
Dr. Asad has nothing to disclose.